The present study aimed to evaluate the effects of immunization with soluble amastigote (AmaAg) and promastigote (ProAg) antigens from Leishmania (Viannia) shawi on the course of infection in BALB/c mice. After immunization with AmaAg, the challenged group showed greater lesion size and parasite load in the skin and lymph nodes, associated with diminished interleukin (IL)-2, IL-4, IL-10, interferon (IFN)-gamma and nitrate levels in the supernatant of lymph node cell cultures, together with increases in transforming growth factor (TGF)-beta concentrations and humoral immune response. In contrast, immunization with ProAg led to smaller lesion size with reduced numbers of viable parasites in the skin. Protection was associated with increases i...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
In this work, the effect of vaccination of a newly described Leishmania infantum antigenic protein h...
Background/PurposeA proper adjuvant has a relevant role in vaccine formulations to generate an effec...
The present study aimed to evaluate the effects of immunization with soluble amastigote (AmaAg) and ...
Background: Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protec...
Leishmania (Viannia) shawi causes cutaneous lesions in humans. Parasite antigens conferring signific...
Leishmania (Viannia) shawi was characterized only recently, and few studies concerning the immunogen...
Abstract Background Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently th...
Leishmania (Viannia) shawl was recently characterized and few studies concerning modifications in ce...
Abstract. Vaccinating with soluble Leishmania major promastigote exogenous antigens (LmSEAgs) protec...
Recent scientific evidence indicates that distinct patterns of susceptibility in BALB/c mice to Leis...
Background/PurposeLeishmaniasis is currently a threat in 80 countries around the world, and cutaneou...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
Soluble Leishmania antigen (SLA) from both developmental stages of L. major (L. major MRHO/IR/75/ER)...
<p>The humoral and cellular response against soluble <i>Leishmania</i> antigens (SLA) was determined...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
In this work, the effect of vaccination of a newly described Leishmania infantum antigenic protein h...
Background/PurposeA proper adjuvant has a relevant role in vaccine formulations to generate an effec...
The present study aimed to evaluate the effects of immunization with soluble amastigote (AmaAg) and ...
Background: Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protec...
Leishmania (Viannia) shawi causes cutaneous lesions in humans. Parasite antigens conferring signific...
Leishmania (Viannia) shawi was characterized only recently, and few studies concerning the immunogen...
Abstract Background Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently th...
Leishmania (Viannia) shawl was recently characterized and few studies concerning modifications in ce...
Abstract. Vaccinating with soluble Leishmania major promastigote exogenous antigens (LmSEAgs) protec...
Recent scientific evidence indicates that distinct patterns of susceptibility in BALB/c mice to Leis...
Background/PurposeLeishmaniasis is currently a threat in 80 countries around the world, and cutaneou...
Gp63 is a major surface protein of Leishmania promastigotes. Its protective efficacy has been tested...
Soluble Leishmania antigen (SLA) from both developmental stages of L. major (L. major MRHO/IR/75/ER)...
<p>The humoral and cellular response against soluble <i>Leishmania</i> antigens (SLA) was determined...
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi an...
In this work, the effect of vaccination of a newly described Leishmania infantum antigenic protein h...
Background/PurposeA proper adjuvant has a relevant role in vaccine formulations to generate an effec...